Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 13Prostatic Neoplasms 11Kidney Neoplasms 9Urinary Bladder Neoplasms 6Testicular Neoplasms 3Neoplasms 3Breast Neoplasms 3Wilms Tumor 2Uterine Cervical Neoplasms 2Testicular Germ Cell Tumor 2Teratoma 2Sarcoma 2Salivary Gland Neoplasms 2Rhabdoid Tumor 2Lymphoma, Large B-Cell, Diffuse 2Central Nervous System Neoplasms 2Burkitt Lymphoma 2Vulvar Neoplasms 1Uterine Cervical Dysplasia 1Urethral Neoplasms 1Teratoma, Testicular 1Squamous Cell Carcinoma of Head and Neck 1Spinal Cord Neoplasms 1Skin Neoplasms 1Recurrence 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Penile Neoplasms 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1

Interventions

Gemcitabine 24Cisplatin 18Carboplatin 10Paclitaxel 9Specimen Handling 6Nivolumab 6Doxorubicin 6Docetaxel 6pembrolizumab 5Magnetic Resonance Spectroscopy 5cabozantinib 4avelumab 4Vinblastine 4Radiotherapy 4Methotrexate 4Fluorouracil 4enfortumab vedotin 3atezolizumab 3aflibercept 3Trastuzumab 3Sunitinib 3Ramucirumab 3Platinum 3Ipilimumab 3CTLA-4 Antigen 3Biopsy 31,2-diaminocyclohexaneplatinum II citrate 3vinflunine 2pegfilgrastim 2Sorafenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urethral Neoplasms × Immunohistochemistry × Genitourinary × Clear all
NCT01118039 2013-08-07

Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
41 enrolled
Genitourinary

Urinary Bladder Neoplasms, Urethral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡